BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance
Takashi Matsushita(Kanazawa University), Kazuhiko Takehara(Kanazawa University), Momoko Tennichi(Kanazawa University), Tomoyo Sawada(Kanazawa University), Minoru Hasegawa(University of Fukui), Yasuhito Hamaguchi(Kanazawa University), Tadahiro Kobayashi(Kanazawa University), Kie Mizumaki(Kanazawa University), Yoichiro Iwakura(Tokyo University of Science), Manabu Fujimoto(Osaka Gakuin University), Miyu Kano(Kanazawa University), Ai Okamura(Kanazawa University)
Cited by 146
Related Papers
A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
|Immunity|2008|1.2k
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
|Journal of Clinical Investigation|2008|907
Idiopathic inflammatory myopathies
|Nature Reviews Disease Primers|2021|683
Production of Mice Deficient in Genes for Interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 Receptor Antagonist Shows that IL-1β Is Crucial in Turpentine-induced Fever Development and Glucocorticoid Secretion
|The Journal of Experimental Medicine|1998|615
Connective Tissue Growth Factor Gene Expression in Tissue Sections From Localized Scleroderma, Keloid, and Other Fibrotic Skin Disorders
|Journal of Investigative Dermatology|1996|438